These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8836790)

  • 1. Serum neuron specific enolase: can it be a tumour marker for renal cell carcinoma?
    Yaman O; Baltaci S; Arikan N; Ozdiler E; Göğüş O; Müftüoğlu YZ
    Int Urol Nephrol; 1996; 28(2):207-10. PubMed ID: 8836790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuron-specific enolase: a serum tumor marker in renal cell carcinoma?
    Gross AJ; Michl UH; Bornhöft G; Dieckmann KP
    Eur Urol; 1993; 24(3):397-9. PubMed ID: 8262110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of serum gamma-enolase and aldolase A in combination as markers for renal cell carcinoma.
    Takashi M; Sakata T; Kato K
    Jpn J Cancer Res; 1993 Mar; 84(3):304-9. PubMed ID: 8486529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical biochemistry of neuron specific enolase.
    Kaiser E; Kuzmits R; Pregant P; Burghuber O; Worofka W
    Clin Chim Acta; 1989 Jul; 183(1):13-31. PubMed ID: 2548772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of gamma-enolase as a tumor marker for renal cell carcinoma.
    Takashi M; Haimoto H; Tanaka J; Murase T; Kato K
    J Urol; 1989 Apr; 141(4):830-4. PubMed ID: 2648028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
    Isgrò MA; Bottoni P; Scatena R
    Adv Exp Med Biol; 2015; 867():125-43. PubMed ID: 26530364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine differentiation in renal cell carcinoma--evaluation of chromogranin A and neuron-specific enolase.
    Rasmuson T; Grankvist K; Roos G; Ljungberg B
    Acta Oncol; 1999; 38(5):623-8. PubMed ID: 10427952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.
    Baudin E; Gigliotti A; Ducreux M; Ropers J; Comoy E; Sabourin JC; Bidart JM; Cailleux AF; Bonacci R; Ruffié P; Schlumberger M
    Br J Cancer; 1998 Oct; 78(8):1102-7. PubMed ID: 9792158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum neuron-specific enolase in diagnosis and follow-up of gastrointestinal neuroendocrine tumors.
    D'Alessandro M; Mariani P; Lomanto D; Carlei F; Lezoche E; Speranza V
    Tumour Biol; 1992; 13(5-6):352-7. PubMed ID: 1290031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum gamma-enolase and prognosis of patients with renal cell carcinoma.
    Rasmuson T; Grankvist K; Ljungberg B
    Cancer; 1993 Aug; 72(4):1324-8. PubMed ID: 8339221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuron-specific enolase--a serum tumour marker in seminoma?
    Fosså SD; Klepp O; Paus E
    Br J Cancer; 1992 Feb; 65(2):297-9. PubMed ID: 1739633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical study of renal cell carcinoma by anti neuron specific enolase (NSE) antibody].
    Senga Y; Satomi Y; Fukuda M; Ebato T; Nakahashi M; Hosaka M; Tanaka Y; Misugi K
    Nihon Hinyokika Gakkai Zasshi; 1988 Nov; 79(11):1818-23. PubMed ID: 3216564
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical significance of serum S100 in metastatic malignant melanoma.
    Guo HB; Stoffel-Wagner B; Bierwirth T; Mezger J; Klingmüller D
    Eur J Cancer; 1995 Oct; 31A(11):1898-902. PubMed ID: 8541129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum neuron-specific enolase in patients with malignant pheochromocytoma.
    Oishi S; Sato T
    Cancer; 1988 Mar; 61(6):1167-70. PubMed ID: 3342373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma.
    Wibe E; Hannisdal E; Paus E; Aamdal S
    Eur J Cancer; 1992; 28A(10):1692-5. PubMed ID: 1389487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-100 and NSE as serum markers in melanoma.
    Tofani A; Cioffi RP; Sciuto R; Rea S; Festa A; Di Filippo F; Cavaliere R; Maini CL
    Acta Oncol; 1997; 36(7):761-4. PubMed ID: 9490097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer.
    O'Shea P; Cassidy M; Freaney R; McCarthy P; Fennelly J
    Ir J Med Sci; 1995 Jan; 164(1):31-6. PubMed ID: 7890531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of an amplified electrophoretic determination of enolase isoenzymes in small cell lung carcinoma patients.
    Batandier C; Brambilla E; Nagy-Mignotte H; Laporte F; Jacrot M; Beriel H; Paramelle B; Brambilla C
    Scand J Clin Lab Invest; 1989 Feb; 49(1):33-42. PubMed ID: 2543057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer.
    Huang Z; Xu D; Zhang F; Ying Y; Song L
    Clin Transl Oncol; 2016 Oct; 18(10):1019-25. PubMed ID: 26886220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
    Wechsel HW; Petri E; Bichler KH; Feil G
    Anticancer Res; 1999; 19(4A):2583-90. PubMed ID: 10470199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.